Skip to main content
OpenTrials
Completed

NCT Number: NCT04825106

Diagnostic Errors in Anaphylactic Shock

Diagnostic accuracy and quality of management in anaphylactic shock is assessed in three conditions: expected, unexpected with no distractor, unexpected with distractor

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnostic Error

Age range

24 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital

Basel, Canton of Basel-City, 4031, Switzerland

About this study

participants: physicians taking part in voluntary workshops. Participants are allocated to teams of three design: prospective, randomized, single-blind setting: simulated anaphylactic shock intervention: participants are allocated to 3 versions of the scenario: 1) expected, 2) unexpected but no distractor, 3) unexpected with distractor

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Physicians taking part in voluntary simulator workshops

Exclusion criteria

  • Refusal to participate or to being videorecorded

Treatment and study plan

Diagnostic context

Other

A life-threatening situation occurs in 3 different contexts

Primary outcomes

  1. Correct diagnosis of anaphylactic shock

    Time frame: 15 minutes

    Diagnosis of anaphylactic shock is explicitly stated by at least one team member within a time frame of 15 minutes after onset

Secondary outcomes

  1. Treatment of anaphylactic shock with epinephrine ≥ 0.3mg intravenously

    Time frame: 5 minutes

    Anaphylactic shock is correctly treated with epinephrine in an appropriate dose (≥ 0.3mg intravenously) within a time frame of 5 minutes after diagnosis

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

Context-dependent Diagnostic Accuracy in Anaphylactic Shock

Acronym: ANASim

Important dates

Study start
2008
Primary completion
2022
Study completion
2022
First posted
Apr 1, 2021
Registry last updated
May 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.